Klatskin Tumors (Hilar Cholangiocarcinoma) - Cleveland Clinic
Hilar cholangiocarcinoma is a form of extrahepatic bile duct cancer. In this condition, you have cancerous tumors on part of your bile duct, outside of your liver. These tumors are known as Klatskin tumors. Healthcare providers may be able to cure this condition if they detect and treat tumors before they spread.
Hilar cholangiocarcinoma: diagnosis, treatment options, and …
2014年2月5日 · The Bismuth-Corlette classification of hilar cholangiocarcinoma. Type I tumors are distal to the hepatic duct confluence (HDC) while type II neoplasms extend to and involve the HDC. Type III tumors involve the HDC and either the proximal right hepatic duct (type IIIA) or proximal left hepatic duct (type IIIB).
Hilar cholangiocarcinoma - Overview - Mayo Clinic
2023年6月6日 · Hilar cholangiocarcinoma is a type of bile duct cancer that occurs in the bile ducts that lead out of the liver (hepatic ducts) and join with the gallbladder. Hilar cholangiocarcinomas are also known as Klatskin tumors.
Hilar Cholangiocarcinoma: expert consensus statement
2015年8月1日 · For patients with locally recurrent or metastatic hilar cholangiocarcinoma, first-line chemotherapy with gemcitabine and cisplatin is recommended based on multiple Phase II trials and a large randomized controlled trial including a heterogeneous population of …
Hilar cholangiocarcinoma: diagnosis and staging - PMC
In patients with hilar cholangiocarcinoma, evaluation must address four critical components of resectability: (1) level and extent of tumor within the biliary tree; (2) vascular invasion; (3) hepatic lobar atrophy; (4) distant meta-static disease.
Multi-Disciplinary Care of Hilar Cholangiocarcinoma: Review of
2023年11月21日 · Hilar cholangiocarcinoma (HC) is a subtype of extrahepatic cholangiocarcinoma that arises from the common hepatic bile duct and can extend to the right and/or left hepatic bile ducts. Upfront surgery with adjuvant capecitabine is the standard of care for patients who present with early disease and the only curative therapy.
Hilar cholangiocarcinoma: Cross sectional evaluation of disease ...
Schematic drawing of Bismuth-Corlette classification of ductal involvement in hilar cholangiocarcinoma. Type I: Tumors below the bifurcation of common hepatic duct; Type II: Tumors involving the bifurcation; but not extending in-to the main right and left duct; Type III: Tumors infiltrating the right (IIIa) or the left (IIIb) hepatic duct;
Hilar Cholangiocarcinoma: expert consensus statement - HPB
For patients with locally recurrent or metastatic hilar cholangiocarcinoma, first-line chemotherapy with gemcitabine and cisplatin is recommended based on multiple Phase II trials and a large randomized controlled trial including a heterogeneous population of patients with biliary cancers.
Non-surgical treatment of hilar cholangiocarcinoma - PMC
2021年11月11日 · For patients with unresectable HC, radiotherapy, chemotherapy, photodynamic therapy, and liver-directed minimally invasive procedures such as percutaneous image-guided ablation and intra-arterial chemoembolization are recommended treatment options.
Hilar Cholangiocarcinoma - SpringerLink
2018年9月12日 · Cholangiocarcinoma is a rare primary malignancy of the bile duct epithelium. Hilar cholangiocarcinoma accounts for 60–70% of all cholangiocarcinomas and originates near the confluence of the right and left hepatic ducts. Established risk factors include liver fluke infection, choledochal cysts and primary sclerosing cholangitis.